CrushSCI.com
提供学术论文选刊润色服务
Gynecologic Oncology 期刊封面 医学
返回期刊列表

Review Cycle Records

Gynecologic Oncology

Elsevier SCIE 非OA
2026新锐 2区2025中科院 2区 TOP2025 JCR Q1
69.9平均天数
59.5中位天数
31最短天数
146最长天数
9302025发文量

Paper Review Records

全部论文审稿周期

10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

54 天

High rates of venous thromboembolism in endometrial cancer patients requiring systemic therapy: an opportunity for risk assessment and intervention

作者Elizabeth G. Thayer; Zoe A. Roecker; Kelsey A. Roof; Hannah B. Gold; Kristen D. Starbuck

作者单位Department of Gynecology and Obstetrics, Emory University School of Medicine, USA; Emory University School of Medicine, USA; Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Emory University School of Medicine, USA

PDF源文件 DOI 网页
139 天

Leveraging artificial intelligence in the early detection of ovarian cancer: Development and validation of a risk prediction model

作者Graham C. Chapman; Oleksii Fedorenko; David Sheyn; Allison Reid; Lauren Taylor; Soumya Ray; Sarah K. Lynam

作者单位Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University Hospitals Cleveland Medical Center, 11100 Euclid Ave, Cleveland, OH 44106, United States of America; Case Western Reserve University School of Medicine, 2109 Adelbert Rd., Cleveland, OH 44106, United States of America; Urology Institute, University Hospitals Cleveland Medical Center, 11100 Euclid Ave, Cleveland, OH 44106, United States of America

PDF源文件 DOI 网页
65 天

Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups

作者Michael T. Richardson; Danika Barry; Jecca R. Steinberg; Kai Holder; Vineeth Thirunavu; Naixin Zhang; Brandon E. Turner; Christopher J. Magnani; Anna Marie P. Young; Connie F. Lu; Natalie A. Squires; Jill N. Anderson; Joshua Cohen; Beth Y. Karlan; John K. Chan; Daniel S. Kapp; Dario R. Roque; Ritu Salani

作者单位Department of Obstetrics and Gynecology, University of California Los Angeles, Los Angeles, CA, United States; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, United States; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, San Francisco, CA, United States; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA, United States; Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States; Division of Gynecologic Oncology, University of Rochester Medical Center, Rochester, NY, United States; Harvard Radiation Oncology Program, Boston, MA, United States; Department of Urology, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, United States; Department of Maternal Fetal Medicine, Brown University/Women and Infants of Rhode Island, Providence, RI, United States; Department of Obstetrics & Gynecology, University of Illinois Chicago, Chicago, IL, United States; Department of Obstetrics and Gynecology, New York-Presbyterian/Weill Cornell Medical Center, New York, NY, United States; Division of Gynecologic Oncology, Department of Surgery, City of Hope Orange County Lennar Foundation Cancer Center, Irvine, CA, USA; California Pacific / Palo Alto Medical Foundation / Sutter Research Institute, San Francisco, CA, United States; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, United States

PDF源文件 DOI 网页
146 天

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination–deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial

作者Shannon N. Westin; Jimmy Belotte; Brunella Felicetti; Vishvajit Aghera; Ahmed YoussefAgha; Evi Bakirtzi; Ana Godoy Ortiz; Arantzazu Barquín García; Diane Provencher; Raúl Márquez Vázquez; Lucia González Cortijo; Xing Zeng; Dan-Arin Silasi; Leslie S. Bradford; Fernanda B. Musa; John K. Chan; Joyce F. Liu; Luis Rojas-Espaillat

作者单位Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; GSK, Waltham, MA, USA; GSK, Stevenage, UK; GSK, Mississauga, Ontario, Canada; GSK, London, UK; Medical Oncology Unit, Virgen de la Victoria University Hospital and Málaga Regional University Hospital, Málaga, Spain; IBIMA Plataforma BIONAND, Málaga, Spain; Genitourinary, Gynecological & Skin Cancer Unit Centro Integral Oncologico HM Clara Campal, Madrid, Spain; Centre Hospitalier de l'Université de Montréal, Université de Montréal and Institut du Cancer de Montréal, Montreal, Quebec, Canada; MD Anderson Madrid, Madrid, Spain; Medical Oncology, Quirónsalud, Madrid, Spain; McGill University Health Centre, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Montreal, Quebec, Canada; Division of Gynecologic Oncology, McGovern Medical School, UTHealth, Houston, TX, USA; MaineHealth Gynecology Cancer Care, Scarborough, ME, USA; Providence-Swedish Cancer Institute, Seattle, WA, USA; Division of Gynecologic Oncology, California Pacific Medical Center, Palo Alto Medical Foundation, Sutter Cancer Research Consortium, San Francisco, CA, USA; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA; Avera Medical Group Gynecologic Oncology, Sioux Falls, SD, USA

PDF源文件 DOI 网页
31 天

Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980–2023) with focus on younger women (0–49 years old)

作者Charlotta Riese; Enoch Yi-Tung Chen; Hanna Nilsson; Sahar Salehi; Anna Sara Oberg; Simon Mathis Kønig; Richard G. Feltbower; Christine Rousset-Jablonski; Magdalena Balcerek; Kenny Rodriguez-Wallberg

作者单位Department of Oncology-Pathology, Karolinska Institute, Karolinska Institutet, Stockholm, Sweden; Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Cancer Epidemiology and Surveillance, Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark; Child Health Outcomes Research at Leeds (CHORAL), University of Leeds, Leeds, UK; Léon Bérard Cancer Center, Femme Mère Enfant Hospital, Hospices civils de Lyon, and INSERM U1290 RESHAPE, Lyon, France; Department of Oncology, Hepatology and Pneumology, University Hospital Leipzig and University Cancer Center Leipzig, Leipzig, Germany; Department of Reproductive Medicine, Division of Gynecology and Reproduction, Karolinska University Hospital, Stockholm, Sweden

PDF源文件 DOI 网页
48 天

Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?

作者Chiara Ainio; Giuseppe Caruso; Sarah Alessi; Annapaola Antonia Aiello; Giuseppe Petralia; Marina N. Rosanu; Lucia Ribero; Pamela I. Causa-Andrieu; Ceylan Colak; Alan H. Stolpen; Luigi A. De Vitis; Amanika Kumar; Carrie L. Langstraat; Michaela E. McGree; Francesco Multinu; Stuart A. Ostby; Gabriella Schivardi; Amanda L. Tapia; Nicoletta Colombo; Giovanni D. Aletti; William A. Cliby

作者单位Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA; Division of Radiology, European Institute of Oncology (IEO), Milan, Italy; Division of Gynecologic Oncology, European Institute of Milan (IEO), IRCCS Milan, Italy; Department of Radiology, Mayo Clinic, Rochester, MN, USA; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy

PDF源文件 DOI 网页
35 天

Persistent low-level real human chorionic gonadotropin after gestational trophoblastic disease: Natural history and predictors of subsequent gestational trophoblastic neoplasia

作者Raphael Alevato; Antônio Braga; Gabriela Paiva; Edward Araujo Júnior; Sue Yazaki Sun; Luana Giongo Pedrotti; Marina Bessel; Solange Artimos de Oliveira; Joffre Amim-Junior; Jorge Rezende-Filho; Ross Berkowitz; Neil Horowitz

作者单位School of Medicine, Fluminense Federal University, Niterói, RJ 24070-090, Brazil; Department of Gynecology and Obstetrics, School of Medicine, Maternity School, Federal University of Rio de Janeiro, Rio de Janeiro, RJ 22240-003, Brazil; Department of General and Specialized Surgery, School of Medicine and Surgery, Federal University of the State of Rio de Janeiro, Rio de Janeiro, RJ 20270-004, Brazil; University of Vassouras, Vassouras, RJ 27700-000, Brazil; Department of Obstetrics, Paulista School of Medicine, Federal University of São Paulo (EPM-UNIFESP), São Paulo 04023-062, SP, Brazil; Hospital Moinhos de Vento, Porto Alegre, RS, Brazil; New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA

PDF源文件 DOI 网页
37 天

Dynamics of HER2 status in recurrent cervical cancer: Highlighting the clinical value of reassessment

作者Jun-Hyeong Seo; Yurimi Lee; Seongyun Lim; Young Eun Chung; Yoo-Young Lee; Chel-Hun Choi; Hyun-Soo Kim; Jeong-Won Lee

作者单位Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

PDF源文件 DOI 网页
72 天

A phase II study of androgen receptor inhibition by darolutamide in combination with leuprolide acetate and exemestane in recurrent adult-type ovarian granulosa cell tumor

作者Elizabeth E. Hopp; Danielle Enserro; Susana Campos; Viola Chitiyo; Gloria Huang; Heather Lankes; Erin K. Crane; Anna Hoekstra; Jean Siedel; Debra L. Richardson; Carol Aghajanian; Janet S. Rader; Allan Covens

作者单位Medical College of Wisconsin Cancer Center, Department of Obstetrics and Gynecology, 8701 W Watertown Plank Rd Milwaukee, WI 53226, USA; NRG Oncology, CTDD Biostatistics & Bioinformatics; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA; Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA; Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; Yale Cancer Center, 35 Park St, New Haven, CT 06519, USA; Division of Gynecologic Oncology, Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA; Levine Cancer Atrium Health Wake Forest Baptist, 1021 Morehead Medical Drive Charlotte, NC 28204, USA; CRC West Michigan Cancer Center, 200 North Park St, Kalamazoo, MI 49007, USA; University of Michigan, 1500 E Medical Center Dr, Ann Arbor, MI 48109, USA; University of Oklahoma, 800 NE 10th Street, Oklahoma City, OK 73104, USA; University of Toronto, Sunnybrook Health Centre, Odette Cancer Centre, 2075 Bayview Ave, Toronto, ON, M4N 3M5, Canada

PDF源文件 DOI 网页
72 天

Quality of life outcomes after sentinel lymph node biopsy in patients with early-stage cervical cancer: Results from the prospective multicentre SENTIX study

作者Roman Kocian; Christhardt Koehler; Giampaolo Di Martino; Jaroslav Klat; Luc van Lonkhuijzen; Jiri Jarkovsky; Michal Zikan; Ignacio Zapardiel; Octavio Arencibia Sanchez; Blanca Gil-Ibanez; Francesco Raspagliesi; Jiri Presl; Lubos Minar; Radim Marek; Peter Kascak; Pavel Havelka; Martin Michal; Toon Van Gorp; Kristyna Nemejcova; Pavel Dundr; Sambor Sawicki; Martina Borcinová; David Cibula

作者单位Gynecologic Oncology Center, Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic; Department of Obstetrics and Gynecology, Albertinen Hospital Hamburg, Germany; Department of Obstetrics and Gynecology, University Hospital Ostrava, Ostrava, Poruba, Czech Republic; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Gynecologic Oncology Unit, La Paz University Hospital, Madrid, Spain; Department of Gynecologic Oncology, Amsterdam University Medical Center, Center for Gynecological Oncology Amsterdam, Amsterdam, Netherlands; Department of Obstetrics and Gynecology, Bulovka University Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic; Department of Gynecologic Oncology, University Hospital of the Canary Islands, Las Palmas de Gran Canaria, Spain; Unit of Gynecological Oncology, Institute Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clinic of Barcelona, Barcelona, Spain; Department of Gynecological Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy; Department of Gynecology and Obstetrics, University Hospital Pilsen, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic; Department of Gynecology and Obstetrics, Faculty of Medicine, Masaryk University, University Hospital Brno, Brno, Czech Republic; Department of Obstetrics and Gynecology, Faculty of Medicine and Dentistry, Palacky University, University Hospital Olomouc, Olomouc, Czech Republic; Department of Gynecology and Obstetrics, Slovak Medical University and University Hospital, Bratislava, Slovak Republic; Department of Obstetrics and Gynecology, KNTB a.s, Zlin, Czech Republic; Department of Obstetrics and Gynecology, Hospital Ceske Budejovice, JSC, Ceske Budejovice, Czech Republic; Department of Gynaecological Oncology, University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic; Gynecologic Oncology Surgical Division, Humanitas San Pio X, Milan 20159, Italy; Gynecology Unit, IRCCS Fondazione San Gerardo dei Tintori, 20900 Monza, Italy; Department of Obstetrics, Gynaecology and Neonatology, Medical University of Gdansk, Poland

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。